These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8544587)

  • 41. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 42. Thrombosis associated with ovarian hyperstimulation syndrome in a carrier of the factor V Leiden mutation.
    Hollemaert S; Wautrecht JC; Capel P; Abramowicz MJ; Englert Y; Delbaere A
    Thromb Haemost; 1996 Aug; 76(2):275-7. PubMed ID: 8865546
    [No Abstract]   [Full Text] [Related]  

  • 43. [Multigenic thrombophilia: genetic anomaly of factor II and mutation of factor V Leiden. Study in a French family].
    Conard J; Mabileau-Brouzes C; Horellou MH; Elalamy I; Samama MM
    Presse Med; 1997 Jun; 26(20):951-3. PubMed ID: 9238178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
    Bathelier C; Champenois T; Lucotte G
    Mol Cell Probes; 1998 Apr; 12(2):121-3. PubMed ID: 9633048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnosis of activated protein C resistance by chronometric test and molecular biology].
    Trossaërt M; Pourkiani N; Conard J; Horellou MH; Delers F; Samama MM
    Rev Med Interne; 1995; 16(6):462-3. PubMed ID: 7652231
    [No Abstract]   [Full Text] [Related]  

  • 46. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
    Dahlbäck B
    Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial thrombophilia: a complex genetic disorder.
    Koeleman BP; Reitsma PH; Bertina RM
    Semin Hematol; 1997 Jul; 34(3):256-64. PubMed ID: 9241710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Resistance to activated protein C. A common genetic risk factor in venous thrombosis].
    Berntorp E; Svensson P; Zöller B; Lethagen S; Dahlbäck B
    Lakartidningen; 1995 Sep; 92(39):3587-90. PubMed ID: 7564599
    [No Abstract]   [Full Text] [Related]  

  • 49. [Multiple phlebothrombosis following cesarean section due to heterozygous factor V Leiden mutation detected post partum].
    Grulich D; Schulze G; Riedel HH
    Zentralbl Gynakol; 1999; 121(11):526-9. PubMed ID: 10612220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activated protein C resistance in childhood stroke.
    Ganesan V; Kelsey H; Cookson J; Osborn A; Kirkham FJ
    Lancet; 1996 Jan; 347(8996):260. PubMed ID: 8551897
    [No Abstract]   [Full Text] [Related]  

  • 51. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.
    Weitz IC; Israel VK; Liebman HA
    Cancer; 1997 May; 79(10):2024-7. PubMed ID: 9149031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A male adolescent with left iliac thrombophlebitis and heterozygosity for factor V Leiden mutation.
    Lovejoy AE; Bush RA; Pong AL; Hilfiker ML
    J Pediatr Surg; 2009 Aug; 44(8):1640-2. PubMed ID: 19635319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.
    Press RD; Goodnight SH
    West J Med; 1995 May; 162(5):450-2. PubMed ID: 7785262
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
    Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
    Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance to activated protein C: role in venous and arterial thrombosis.
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Biomed Pharmacother; 1996; 50(6-7):254-60. PubMed ID: 8952864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B; Hillarp A; Berntorp E; Dahlbäck B
    Annu Rev Med; 1997; 48():45-58. PubMed ID: 9046944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid two-stage PCR for detecting factor V G1691A mutation.
    Beauchamp NJ; Daly ME; Cooper PC; Preston FE; Peake IR
    Lancet; 1994 Sep; 344(8923):694-5. PubMed ID: 7915391
    [No Abstract]   [Full Text] [Related]  

  • 59. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
    Tans G; Nicolaes GA; Rosing J
    Semin Hematol; 1997 Jul; 34(3):244-55. PubMed ID: 9241709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postpartum seizures after epidural analgesia: a patient with a mutation of the factor V Leiden and prothrombin gene.
    van Nordennen J; Camu F
    J Clin Anesth; 2007 Nov; 19(7):549-50. PubMed ID: 18063213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.